Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world treatment patterns and outcomes in chronic lymphocytic leukemia: a multicenter retrospective study in Greece.

Annals of hematology·2026
Same author

Real-World Application of a Machine Learning Pipeline for Overall Survival in Chronic Lymphocytic Leukemia.

Studies in health technology and informatics·2026
Same author

Therapy-driven clonal dynamics in chronic lymphocytic leukemia.

Seminars in cancer biology·2026
Same author

Longitudinal profiling of antigen receptor gene repertoire dynamics in kidney transplant recipients after multiple SARS-CoV-2 vaccinations.

ImmunoHorizons·2026
Same author

Filling the Gaps in Health Data: Using a Machine Learning Approach to Augment Partially Observed Variables Such as Smoking in Claims Data.

Pharmacoepidemiology and drug safety·2026
Same author

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis.

Leukemia·2026
Same journal

A GenAI Pipeline for Violinist Kinematic Data Management.

Studies in health technology and informatics·2026
Same journal

AMAL-For-Qatar: A Comprehensive AI Ecosystem for Fetal Ultrasound Analysis - Project Overview and Achievements.

Studies in health technology and informatics·2026
Same journal

Longitudinal Treatment-Aware Multimodal AI for Dermatology: A Scoping Review.

Studies in health technology and informatics·2026
Same journal

Predicting Postpartum Depression Using Imbalance-Aware Machine Learning.

Studies in health technology and informatics·2026
Same journal

Validation of Deep-Learning Models for Autosegmentation of Brain Metastases.

Studies in health technology and informatics·2026
Same journal

Delay-Dependent Gating in Modular RNNs.

Studies in health technology and informatics·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Building Robust Foundations for Data Interoperability in Hematological Malignancies.

Evangelia Minga1,2, Christina Papangelou1, Thomas Chatzikonstantinou1

  • 1Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.

Studies in Health Technology and Informatics
|May 23, 2026
PubMed
Summary
This summary is machine-generated.

We developed a flexible knowledge base for collecting real-world data in multi-center hematological malignancy studies. This enhances data interoperability and reusability for future research applications.

Keywords:
Data HarmonizationKnowledge BaseReal-World Data

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Area of Science:

  • Clinical Research Informatics
  • Hematology
  • Data Science

Background:

  • Multi-center clinical studies for hematological malignancies generate complex real-world data.
  • Ensuring data interoperability and reusability is crucial for advancing cancer research.
  • Existing data collection methods may lack flexibility and scalability for diverse research needs.

Purpose of the Study:

  • To create a robust knowledge base for collecting real-world data in hematological malignancy research.
  • To enable seamless data interoperability and reusability across different research projects.
  • To provide a flexible, scalable, and extensible data collection framework.

Main Methods:

  • Leveraging expertise in designing methodologies for real-world data collection.
  • Developing a knowledge base specifically for multi-center clinical studies.
  • Implementing a framework applicable to various use-case scenarios.

Main Results:

  • A knowledge base enabling interoperability and reusability of real-world data was created.
  • The developed approach demonstrated flexibility, scalability, and extensibility.
  • The framework is suitable for diverse research applications in hematological malignancies.

Conclusions:

  • The developed knowledge base significantly improves real-world data management for hematological malignancy studies.
  • This approach facilitates efficient data sharing and collaborative research.
  • The flexible framework supports the evolving needs of clinical research.